Pfanstiehl, Inc.
Denis Ovoshchnikov M.S. serves as a Scientist I and Stability Testing Project Leader at Pfanstiehl, Inc. since September 2021, overseeing stability testing projects and training new scientists. Prior experience includes a role as a Graduate Student Researcher at Rush University, focusing on biomechanical functions of human joints and conducting an internship in Innovation and Technology Transfer. Denis also worked as an IT Team Leader at CountBOX US, a Dental Assistant at Bridgeport Smiles of Chicago, and a Logistics Coordinator at ANS Consulting Group. Academic credentials include a Master of Science in Biotechnology from Rush University and a Bachelor of Science in Biological Sciences and History from the University of Illinois Chicago.
This person is not in any teams
Pfanstiehl, Inc.
1 followers
Founded in 1919 by Carl A. Pfanstiehl, our company specializes in isolation, purification, custom synthesis and scale-up development of cGMP, high purity and low endotoxin (HPLE) Injectable Formulation Components, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API’s), in gram to multi-ton commercial quantities. Tried and true parenteral excipients include trehalose, sucrose, mannitol, maltose, sorbitol, and hydroxypropyl betacyclodextrin. Upstream, high purity media components include animal component free galactose, mannose, and L-arginine. At Pfanstiehl we pride ourselves on being customer focused and are amenable to producing cGMP components on a custom basis to solve formulation challenges for our clients.